Hu, F., Hu, C., He, Y., Guo, L., Sun, Y., Han, C., . . . Yang, S. IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. MDPI AG.
Chicago Style (17th ed.) CitationHu, Feiming, et al. IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. MDPI AG.
MLA (9th ed.) CitationHu, Feiming, et al. IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma. MDPI AG.
Warning: These citations may not always be 100% accurate.